ASCO 2026: Breast Cancer Highlights with Dr. Kim Ma.

Dr. Kim Ma shares key ASCO 2026 updates in early breast cancer, including evidence supporting omission of axillary lymph node dissection in selected patients and promising neoadjuvant results from the Neo-Healer trial in HER2-positive disease.